![HITTING A MOVING TARGET](https://thenativeantigencompany.com/wp-content/uploads/2023/03/AdobeStock_274987196-1080x675.jpeg)
![HITTING A MOVING TARGET](https://thenativeantigencompany.com/wp-content/uploads/2023/03/AdobeStock_274987196-1080x675.jpeg)
![Influenza antigens for Northern Hemisphere’s 2023-2024 flu season](https://thenativeantigencompany.com/wp-content/uploads/2023/02/TNAC-Blog-Size.png)
Influenza antigens for Northern Hemisphere’s 2023-2024 flu season
Most recent figures published by UK Health Security Agency show that the 2022/2023 Influenza season has been worse than any of the past surveillance periods (GOV.UK, 2023). High level of Influenza incidence increased the burden on the National Health Service,...![The Native Antigen Company introduces new range of influenza antigens](https://thenativeantigencompany.com/wp-content/uploads/2022/11/Influenza-Virus-09-1-1000x675.jpg)
The Native Antigen Company introduces new range of influenza antigens
Season-specific Haemagglutinin and Neuraminidase antigens will support vaccine and diagnostic reformulation programmes New range developed to cover 2023 southern hemisphere flu season Oxford, UK, 14 November 2022: The Native Antigen Company (part of LGC Clinical...![The Yearly Race for an Influenza Vaccine and the Role of Reagents](https://thenativeantigencompany.com/wp-content/uploads/2020/08/Influenza-Virus-01-1000x675.jpg)